Skip to main content
. Author manuscript; available in PMC: 2010 Apr 8.
Published in final edited form as: Circ Cardiovasc Genet. 2009 Dec 3;3(1):22–30. doi: 10.1161/CIRCGENETICS.109.862748

Table 3.

The Subsamples of Women (n=3686, I=70) Defined by the Step 1 PRIM Analysis

Subsample, n (%) Cumulative Incidence (95% CI) Description Subgroup, n (%)
FS 1, 764 (20.7) I=139 (119, 161) Age ≥65 y and TG ≥150 mg/dL (and SMK and/or HYT) 764 (20.7)
FS 2, 839 (22.8) I=99 (82, 128) Age ≥65 y and TG <150 mg/dL and HYT 799 (21.7)
Or
Age ≥65 y and TG <150 mg/dL and SMK and no HYT and DIAB 6 (0.2)
Or
Age 45 to 64 y and SMK and DIAB 34 (0.9)
FS 3, 2083 (56.5) I=33 (25, 41) Age ≥65 y and no SMK and no HYT 177 (4.8)
Or
Age ≥65 y and TG <150 mg/dL and SMK and no HYT and no DIAB 157 (4.3)
Or
Age 45 to 64 y and (no SMK and/or no DIAB) 1749 (47.4)

I indicates number of cases per 1000 individuals at risk; HYT, history of hypertension; DIAB, history of diabetes; SMK, history of smoking.